BSX

Boston Scientific Corporation

Healthcare
44.03 -0.59 -1.32% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 65.44B
EV 75.02B
Shares Out 1.49B
Revenue (ttm) 20.61B
Net Income 3.56B
Beta —
P/E —
Forward P/E —
EPS (ttm) $2.39
P/S 3.17
P/B 2.53
P/FCF 18.81
P/C 15.06
EV/Sales 3.64
EV/EBITDA 14.46
ROA 8.3%
ROE 14.77%
ROIC 9.78%
Gross Margin 69.17%
Oper. Margin 18.4%
Profit Margin 17.29%
Debt/Eq 0.43
LT Debt/Cap 29.82%
Quick Ratio 0.98
Current Ratio 1.90
Book/sh 17.42
Cash/sh 0.98
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -0.6%
SMA50 -9.35%
SMA200 -41.88%
Volume 15,515,345
Avg Volume 19.01M
Rel Volume 0.82
Perf Week -1.39%
Perf Month -2.78%
Perf Quarter -27.81%
Perf Half Y -51.72%
Perf YTD -53.82%
Perf Year -57.52%
Perf 3Y -17.64%
Perf 5Y 2.90%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The company…

Name
Boston Scientific Corporation
Industry
Medical Devices
CEO
Michael F. Mahoney · Chairman of the Board of Directors, President and Chief Executive Officer
Employees
59,000 as of 2025-12-31
IPO Date
2020-06-18
Phone
(508) 683-4000
Address
300 Boston Scientific Way, Marlborough, MA 01752-1234
Website
www.bostonscientific.com

Key Executives

Name Title FY Pay
Michael F. Mahoney Chairman of the Board of Directors, President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.